Where is the room for improvement in the drug treatment of depression and anxiety?

S41744, a dual neurokinin (NK)1 receptor antagonist and serotonin (5-HT) reuptake inhibitor with potential antidepressant properties: A comparison to aprepitant (MK869) and paroxetine

(2010) Mark J. Millan et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder

(2010) Yan-Feng Zou et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

The β3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changes

(2010) Alessandra Tamburella et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Variation in GNB3 predicts response and adverse reactions to antidepressants

(2010) Robert Keers et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Review: The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target?

(2010) Ramamoorthy Rajkumar et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Neuropeptide Y (NPY) gene: Impact on emotional processing and treatment response in anxious depression

(2009) Katharina Domschke et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

HTR2A gene variation is involved in antidepressant treatment response

(2009) Susanne Lucae et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study

(2009) Borwin Bandelow et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Effects of aripiprazole adjunctive to standard antidepressant treatment on the core symptoms of depression: A post-hoc, pooled analysis of two large, placebo-controlled studies

(2009) J. Craig Nelson et al.   JOURNAL OF AFFECTIVE DISORDERS

The anxiolytic effect of pregabalin in outpatients undergoing minor orthopaedic surgery

(2009) Christopher Gonano et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levels

(2009) LS Volonteri et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

(2009) Andrea Cipriani et al.   LANCET

Room for Improvement in the Pharmacological Treatment of Anxiety Disorders

(2008) D. Baldwin   CURRENT PHARMACEUTICAL DESIGN

Early onset anxiolytic efficacy after a single dose of pregabalin: double-blind, placebo- and active-comparator controlled evaluation using a dental anxiety model

(2008) D. Nutt et al.   JOURNAL OF PSYCHOPHARMACOLOGY